Frontline: Surgery to remove the tumor is often considered, sometimes followed by chemotherapy or radiation to reduce ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...

The early-stage clinical trial marks the first U.S. testing of Alveltamig, an immunotherapy designed to help the immune system better recognize and respond to small cell lung cancer. The study aims to ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

Despite a significant 48.8% objective response rate and breakthrough therapy status, this regulatory shift reverses years of ...

Dr. Zhonglin Hao says small cell lung cancer usually occurs in smokers and often recurs after treatments that are currently available. (University of Kentucky photo) If you smoke and want to quit, ...

Small cell lung cancer, or SCLC, is aggressive, lethal and particularly cruel because chemotherapy initially works so well. But within just a few months, SCLC becomes resistant to drugs and dashes ...

Then you have the fact that clinical trials often underrepresent minorities. This can lead to skewed AI models, with 80 ...

Sunvozertinib is the first targeted oral treatment for NSCLC with EGFR exon 20 insertion mutations, approved for post-chemotherapy progression cases. The WU-KONG1 Part B study showed a 53.3% objective ...